A New Pathway for Antibiotic Innovation: Exploring Drug Development for Limited Populations

Article Read time:
Projects: Antibiotic Resistance
A New Pathway for Antibiotic Innovation: Exploring Drug Development for Limited Populations

The Pew Charitable Trusts held a one-day conference, “A New Pathway for Antibiotic Innovation: Exploring Drug Development for Limited Populations” on Thursday, January 31, 2013.

As multidrug-resistant infections have grown more prevalent, few new antibiotics are reaching the market. This is attributed, in part, to the economic and regulatory challenges associated with their development. Recently, stakeholders have endorsed a novel regulatory pathway to approve these lifesaving drugs for use in limited patient populations — namely those at highest risk and with few or no other options. Leaders representing the drug industry, health care providers, government regulators and payors came together to advance this concept and explore its feasibility from a business and public health perspective.

The Pew Charitable Trusts makes every effort to comply with federal, state and local government ethics rules when hosting events. Please make sure that your participation is consistent with applicable ethics rules.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
RELATED
Projects
Antibiotic Resistance
Related Links

Full Transcript Rewarding Antibiotic Development And Responsible Stewardship (RADARS) Agenda Speaker Biographies Background Materials

ADDITIONAL RESOURCES

A sick child with a man consulting with a doctor through a video call on a smartphone from home.

Article

October 27, 2023 How to Incorporate Antibiotic Stewardship Into Telemedicine
Four decontamination operatives at work in green and yellow

Opinion

February 6, 2023 Antibiotics Are Vital to National Health and Security
Shot of a doctor examining a woman’s throat during a consultation

Fact Sheet

January 27, 2023 Inappropriate Antibiotic Prescribing Comes With Risks

MORE FROM PEW

An aerial view of a vast wetland, with scattered vegetation visible on sandy islands. In Western Australia, a Conservation Model for the World
A presentation being given by a businesswoman to a group of participants at a business conference. Four Plan Features Can Boost 'Retirement Readiness'
A large group of people in formal or traditional attire stands together on a stage, with a digital background depicting marine life and the large text “WTO Agreement on Fisheries Subsidies.” WTO Needs to Redouble Its Effort on Fishing Subsidies
A man in a winter hat and sunglasses kneels on a rocky shoreline in front of a campfire, holding a metal mug with gloved hands. Behind him, in the water, a motorboat is moored to the shore. Cliffs rise on both sides of the water. Why Newfoundland’s South Coast Fjords Are Sacred
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics
Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.
Quick View
Pills illustration

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.